Alfavision Overseas (India) Limited
BSE: ALFAVIO
Prev Close
5.86
Open Price
5.98
Volume
717
Today Low / High
5.86 / 5.98
52 WK Low / High
5.66 / 16.66
Range
6 - 6
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 5.88, reflecting a change of 0.02 (0.3413%). The expected target range on the BSE is 6 - 6. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Alfavision Overseas (India) Limited Graph
Alfavision Overseas (India) Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Alfavision Overseas (India) Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 5.88, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 5.88 | 5.94 | 5.34 - 6.53 |
| 6.00 | 4.80 - 7.20 | ||
| 6.06 | 4.24 - 7.87 | ||
| Bearish Scenario | 5.88 | 5.82 | 5.24 - 6.40 |
| 5.76 | 4.61 - 6.91 | ||
| 5.70 | 3.99 - 7.41 |
Overview of Alfavision Overseas (India) Limited
ISIN
INE883B01027
Industry
Biotechnology
Vol.Avg
12,310
Market Cap
185,372,880
Last Dividend
0
Official Website
IPO Date
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Stock Dividend of ALFAVIO
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2022-09-29 | September 29, 22 | 0.05 | 0.05 | 2022-09-29 | 2022-10-30 | |
| 2021-09-22 | September 22, 21 | 0.02 | 0.2 | 2021-09-23 | 2021-10-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.91 Cr | 1.63 Cr | 0.28 Cr | 0.1458 | 0.00 Cr | 0.00 Cr | 0.11 Cr | 0.12 Cr | 0.04 | 0.16 Cr | 0.0639 |
| 2024-03-31 | 3.13 Cr | 2.08 Cr | 1.38 Cr | 0.4423 | 0.00 Cr | 0.03 Cr | 0.92 Cr | 0.28 Cr | 0.09 | 1.01 Cr | 0.0884 |
| 2023-03-31 | 30.81 Cr | 28.14 Cr | 2.67 Cr | 0.0868 | 0.00 Cr | 0.07 Cr | 2.29 Cr | 0.68 Cr | 0.22 | 2.28 Cr | 0.0221 |
| 2022-03-31 | 181.57 Cr | 175.72 Cr | 5.85 Cr | 0.0322 | 0.00 Cr | 0.18 Cr | 4.84 Cr | 2.01 Cr | 0.64 | 6.16 Cr | 0.0111 |
| 2021-03-31 | 179.10 Cr | 173.35 Cr | 5.74 Cr | 0.0321 | 0.00 Cr | 0.09 Cr | 3.91 Cr | 1.49 Cr | 0.47 | 4.93 Cr | 0.0083 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.08 Cr | 178.93 Cr | 136.84 Cr | 42.0926 Cr | 135.66 Cr | 135.58 Cr | 0.00 Cr | 30.23 Cr | 0.00 Cr | 0.00 Cr | 120.97 Cr | 1.1189 Cr |
| 2024-03-31 | 0.17 Cr | 178.56 Cr | 136.59 Cr | 41.9709 Cr | 124.36 Cr | 124.19 Cr | 0.00 Cr | 30.27 Cr | 0.00 Cr | 0.00 Cr | 0.62 Cr | 0.8783 Cr |
| 2023-03-31 | 0.13 Cr | 204.84 Cr | 161.56 Cr | 41.6909 Cr | 125.03 Cr | 156.40 Cr | 4.93 Cr | 30.35 Cr | 1.09 Cr | 0.00 Cr | 1.76 Cr | 0.4649 Cr |
| 2022-03-31 | 0.91 Cr | 316.88 Cr | 271.27 Cr | 45.6012 Cr | 143.15 Cr | 142.24 Cr | 1.05 Cr | 30.38 Cr | 0.05 Cr | 0.00 Cr | 0.00 Cr | 142.0078 Cr |
| 2021-03-31 | 0.21 Cr | 115.44 Cr | 101.92 Cr | 13.5136 Cr | 54.72 Cr | 54.52 Cr | 0.58 Cr | 0.48 Cr | 1.50 Cr | 0.00 Cr | 0.00 Cr | 77.6370 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -0.0862 Cr | -0.0145 Cr | 0.0074 Cr | -0.0862 Cr | -0.0933 Cr | 0.0772 Cr | 0.0000 Cr | 0.1218 Cr | 0.0099 Cr | 0.0000 Cr | 0.0000 Cr |
| 2024-03-31 | -9.7203 Cr | 1.1312 Cr | 8.6426 Cr | -9.7251 Cr | 0.0535 Cr | 0.1705 Cr | 0.0000 Cr | 0.2764 Cr | 9.3420 Cr | 0.0000 Cr | 0.0000 Cr |
| 2023-03-31 | 2.5515 Cr | -16.0073 Cr | 13.9043 Cr | 2.5325 Cr | -0.7775 Cr | 0.1330 Cr | -0.0190 Cr | -2.1531 Cr | 15.6156 Cr | -0.1634 Cr | 1.0461 Cr |
| 2022-03-31 | -2.7054 Cr | -81.7441 Cr | 85.1528 Cr | -2.7054 Cr | 0.7033 Cr | 0.9105 Cr | 0.0000 Cr | 2.1290 Cr | 89.0728 Cr | 0.0000 Cr | -0.4633 Cr |
| 2021-03-31 | -2.6288 Cr | -0.1726 Cr | 2.4290 Cr | -2.8028 Cr | -0.3724 Cr | 0.2072 Cr | -0.1740 Cr | 1.6925 Cr | 5.5711 Cr | 0.0000 Cr | -0.5827 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 1.32 Cr | 1.21 Cr | 0.11 Cr | 0.0848 | 0.08 Cr | 0.09 Cr | 0.03 | 0.10 Cr | 0.0675 |
| 2025-03-31 | 0.00 Cr | 0.01 Cr | -0.01 Cr | 0.0000 | -0.08 Cr | -0.08 Cr | -0.03 | -0.07 Cr | 0.0000 |
| 2024-12-31 | 0.49 Cr | 0.44 Cr | 0.05 Cr | 0.1096 | 0.00 Cr | 0.01 Cr | 0.00 | 0.02 Cr | 0.0252 |
| 2024-09-30 | 0.44 Cr | 0.27 Cr | 0.18 Cr | 0.4023 | 0.12 Cr | 0.12 Cr | 0.04 | 0.13 Cr | 0.2735 |
| 2024-06-30 | 0.97 Cr | 0.80 Cr | 0.17 Cr | 0.1734 | 0.09 Cr | 0.09 Cr | 0.03 | 0.10 Cr | 0.0892 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 0.08 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -42.09 Cr |
| 2025-03-31 | 0.08 Cr | 0.24 Cr | 0.32 Cr | 27.36 Cr | 0.00 Cr | 27.68 Cr | 30.23 Cr | 178.93 Cr | 136.84 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 0.17 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -42.18 Cr |
| 2024-09-30 | 0.17 Cr | 0.24 Cr | 0.40 Cr | 27.22 Cr | 0.00 Cr | 27.63 Cr | 30.25 Cr | 178.89 Cr | 136.71 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 0.17 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -41.97 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 0.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | -0.10 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 0.01 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 0.12 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2022-08-29 | August 29, 22 | 10:1 |
Similar Stocks: Biotechnology
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Biocon Limited | BIOCON | ₹392.65 | ₹524,217,589,044.00 | ₹4,216,726.00 |
| Anthem Biosciences Ltd. | ANTHEM | ₹654.45 | ₹367,545,697,877.00 | ₹172,953.00 |
| Syngene International Limited | SYNGENE | ₹639.80 | ₹257,017,837,938.00 | ₹433,951.00 |
| Piramal Pharma Limited | PPLPHARMA | ₹179.85 | ₹237,953,612,540.00 | ₹2,245,375.00 |
| Onesource Specialty Pharma Ltd. | ONESOURCE | ₹1,685.80 | ₹193,066,609,133.00 | ₹197,165.00 |
| Concord Biotech Limited | CONCORDBIO | ₹1,408.40 | ₹147,341,461,714.00 | ₹51,258.00 |
| Jubilant Ingrevia Limited | JUBLINGREA | ₹687.30 | ₹108,574,719,186.00 | ₹87,235.00 |
| Blue Jet Healthcare Limited | BLUEJET | ₹544.60 | ₹94,469,270,455.00 | ₹181,910.00 |
| Supriya Lifescience Limited | SUPRIYA | ₹745.20 | ₹59,975,782,560.00 | ₹103,732.00 |
| Zota Health Care Limited | ZOTA | ₹1,579.10 | ₹47,898,295,511.00 | ₹22,133.00 |
| Dishman Carbogen Amcis Limited | DCAL | ₹222.80 | ₹34,931,273,566.00 | ₹154,304.00 |
Key Executives
Gender: male
Year Born: 1991
Gender: male
Year Born: 1965
Gender: male
Year Born:
FAQs about Alfavision Overseas (India) Limited
The CEO is Vishnu Prasad Goyal.
The current price is ₹5.88.
The range is ₹5.66-16.66.
The market capitalization is ₹18.54 crores.
The P/E ratio is 124.79.
The company operates in the Healthcare sector.
Overview of Alfavision Overseas (India) Limited (ISIN: INE883B01027) is a leading Biotechnology in India. With a market capitalization of ₹18.54 crores and an average daily volume of 12,310 shares, it operates in the Biotechnology. The company last declared a dividend of ₹0.